Aharon Gil 4
4 · DELCATH SYSTEMS, INC. · Filed May 14, 2026
Research Summary
AI-generated summary of this filing
Delcath (DCTH) Director Aharon Gil Receives 22,500-Share Option Grant
What Happened
- Aharon Gil, a director of Delcath Systems, Inc. (DCTH), received a grant of a derivative award on 2026-05-13 covering 22,500 shares. The filing shows an acquisition at $0.00 (reporting value $0), indicating an option/award rather than an open-market purchase or sale.
Key Details
- Transaction date: 2026-05-13; Filing date: 2026-05-14 (timely).
- Instrument: derivative option/award for 22,500 shares shown at $0.00.
- Vesting: 1/12th of the option vests monthly starting May 13, 2026 (fully vests after 12 months, subject to continued service).
- Expiration: earlier of 10 years from grant or, for vested options, two years from last day of service (per footnote).
- Shares owned after transaction: not specified in the filing.
- No indication of a 10b5-1 plan, tax withholding, or sale; this is a grant (code A) rather than a purchase (P) or sale (S).
Context
- This was an option/award grant to a director. For retail investors, grants signal compensation alignment with shareholders but do not necessarily indicate immediate buying or selling of stock. The option vests monthly, so any future exercises or sales would be reported separately.
Insider Transaction Report
Form 4
Aharon Gil
Director
Transactions
- Award
Stock Option (right to buy)
[F1]2026-05-13+22,500→ 22,500 totalExercise: $11.61→ Common Stock (22,500 underlying)
Footnotes (1)
- [F1]The option will vest and become exercisable at the rate of one-twelfth (1/12th) per month with the first such vesting to occur on May 13, 2026 and monthly thereafter for so long as the reporting person remains a director of the Issuer (and subject to the terms and conditions of the Issuer's 2020 Omnibus Equity Incentive Plan, as amended). The option will expire the earlier of 10 years from the grant date or, for vested options, two years from the last day of service.
Signature
/s/ Gerard Michel, Attorney-in-Fact|2026-05-14